| [1] |
World Health Organization(WHO). Cardiovascular diseases(CVDs).[EB/OL]. (2023-09-22)[2024-12-03].
|
| [2] |
|
| [3] |
|
| [4] |
BLAHA M J, GLUCKMAN T J, BLUMENTHAL R S. Preventive cardiology[M]//Preventive Cardiology: Companion to Braunwald's Heart Disease. Amsterdam: Elsevier, 2011: 1-13.
|
| [5] |
FORD E S, AJANI U A, CROFT J B, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000[J]. N Engl J Med, 2007, 356(23): 2388-2398.
|
| [6] |
社区成人血脂管理中国专家共识撰写组,李勇,祝珠,等. 社区成人血脂管理中国专家共识(2024年)[J]. 中华全科医师杂志, 2024, 23(3): 220-228.
|
| [7] |
SEBASTIAN S A. Cardiovascular disease risk communication: Strategies, impact, and future directions[J]. Curr Probl Cardiol, 2024, 49(5): 102490. DOI: 10.1016/j.cpcardiol.2024.102490.
|
| [8] |
KAVITA, THAKUR J S, VIJAYVERGIYA R, et al. Task shifting of cardiovascular risk assessment and communication by nurses for primary and secondary prevention of cardiovascular diseases in a tertiary health care setting of Northern India[J]. BMC Health Serv Res, 2020, 20(1): 10. DOI: 10.1186/s12913-019-4864-9.
|
| [9] |
|
| [10] |
ARNETT D K, BLUMENTHAL R S, ALBERT M A, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines[J]. Circulation, 2019, 140(11): e596-646.
|
| [11] |
GUO Z T, TANG J Y, HAN H Y, et al. Cardiovascular disease risk prediction models in the Chinese population-asystematic review and meta-analysis[J]. BMC Public Health, 2022, 22(1): 1608. DOI: 10.1186/s12889-022-13995-z.
|
| [12] |
王旭阳,郭芝廷,张玉萍,等. 心血管疾病风险沟通的研究进展[J]. 中华护理杂志, 2024, 59(15): 1916-1921.
|
| [13] |
巩超,刘秋萍,王佳敏,等. 社区人群他汀干预策略预防心血管病效果的马尔可夫模型评价[J]. 北京大学学报(医学版), 2022, 54(3): 443-449.
|
| [14] |
|
| [15] |
ARNETT D K, KHERA A, BLUMENTHAL R S. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: part 1, lifestyle and behavioral factors[J]. JAMA Cardiol, 2019, 4(10): 1043-1044. DOI: 10.1001/jamacardio.2019.2604.
|
| [16] |
|
| [17] |
孙照阳,张巧,徐淑静,等. 四种不同风险评估模型评估贵阳地区40岁以上人群10年心血管疾病风险的研究[J]. 贵州医药, 2018, 42(8): 1007-1010.
|
| [18] |
徐嘉纯,常进,宫海滨. 动脉粥样硬化性心血管疾病风险评估对中国高血压防治的启示[J]. 中国心血管病研究, 2019, 17(3): 207-210, 241.
|
| [19] |
|
| [20] |
YANG X L, LI J X, HU D S, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project(prediction for ASCVD risk in China)[J]. Circulation, 2016, 134(19): 1430-1440. DOI: 10.1161/CIRCULATIONAHA.116.022367.
|
| [21] |
中国心血管病风险评估和管理指南编写联合委员会,顾东风. 中国心血管病风险评估和管理指南[J]. 中华预防医学杂志, 2019, 53(1): 13-35.
|
| [22] |
于晓松,路孝琴. 全科医学概论[M]. 5版. 北京: 人民卫生出版社, 2018.
|
| [23] |
|
| [24] |
|
| [25] |
王箴,钱菊英,潘柏申,等. 一种基于信息化系统的智能化动脉粥样硬化性心血管疾病风险评估工具的开发应用[J]. 上海医学, 2021, 44(11): 795-801.
|